A detailed history of Manufacturers Life Insurance Company, The transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 33,554 shares of AVIR stock, worth $107,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,554
Previous 34,886 3.82%
Holding current value
$107,037
Previous $115,000 2.61%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$3.17 - $4.02 $4,222 - $5,354
-1,332 Reduced 3.82%
33,554 $112,000
Q2 2024

Aug 14, 2024

BUY
$3.31 - $4.04 $14,362 - $17,529
4,339 Added 14.2%
34,886 $115,000
Q1 2024

May 14, 2024

SELL
$3.09 - $4.56 $7,533 - $11,117
-2,438 Reduced 7.39%
30,547 $123,000
Q3 2023

Nov 15, 2023

BUY
$3.0 - $3.79 $138 - $174
46 Added 0.14%
32,985 $98,000
Q2 2023

Aug 11, 2023

SELL
$3.21 - $5.06 $600,809 - $947,070
-187,168 Reduced 85.04%
32,939 $123,000
Q1 2023

May 15, 2023

SELL
$3.0 - $4.97 $569,100 - $942,809
-189,700 Reduced 86.19%
30,407 $101,000
Q4 2022

Aug 11, 2023

BUY
$4.35 - $6.17 $1,348 - $1,912
310 Added 0.14%
220,107 $1.06 Million
Q4 2022

Feb 13, 2023

BUY
$4.35 - $6.17 $1,348 - $1,912
310 Added 0.14%
220,107 $1.06 Million
Q3 2022

Aug 11, 2023

SELL
$5.49 - $8.79 $2,805 - $4,491
-511 Reduced 0.23%
219,797 $1.25 Million
Q3 2022

Nov 03, 2022

SELL
$5.49 - $8.79 $2,805 - $4,491
-511 Reduced 0.23%
219,797 $1.25 Million
Q2 2022

Aug 11, 2023

SELL
$5.33 - $8.18 $204,389 - $313,678
-38,347 Reduced 14.83%
220,308 $1.56 Million
Q2 2022

Aug 15, 2022

SELL
$5.33 - $8.18 $204,389 - $313,678
-38,347 Reduced 14.83%
220,308 $1.56 Million
Q1 2022

Aug 11, 2023

BUY
$5.5 - $9.19 $1.26 Million - $2.1 Million
228,248 Added 750.64%
258,655 $1.87 Million
Q1 2022

May 20, 2022

BUY
$5.5 - $9.19 $192,500 - $321,650
35,000 Added 15.65%
258,655 $1.86 Million
Q4 2021

Feb 16, 2022

SELL
$7.67 - $44.59 $458,420 - $2.67 Million
-59,768 Reduced 21.09%
223,655 $2.01 Million
Q3 2021

Nov 12, 2021

SELL
$21.33 - $35.06 $72,884 - $119,800
-3,417 Reduced 1.19%
283,423 $9.94 Million
Q2 2021

Aug 12, 2021

BUY
$19.22 - $59.08 $525,936 - $1.62 Million
27,364 Added 10.55%
286,840 $6.16 Million
Q1 2021

May 03, 2021

BUY
$41.42 - $88.44 $49,331 - $105,332
1,191 Added 0.46%
259,476 $16 Million
Q4 2020

Feb 12, 2021

BUY
$26.36 - $41.78 $6.81 Million - $10.8 Million
258,285 New
258,285 $10.8 Million

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $266M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.